Federated Hermes, Inc. Protara Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$2.43 - $3.7 $296 - $451	-122 Reduced 49.59%	124 $0
Q3 2022 Nov 14, 2022	SELL	$2.96 - $4.27 $396 - $572	-134 Reduced 35.26%	246 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.8 - $5.33 $128 - $245	-46 Reduced 10.8%	380 $1,000
Q1 2022 May 13, 2022	BUY	$4.19 - $6.9 $1,240 - $2,042	296 Added 227.69%	426 $2,000
Q4 2021 Feb 14, 2022	BUY	$6.15 - $7.76 $799 - $1,008	130 New	130 $1,000

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $26.9M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.